Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG)

Japanese Journal of Clinical Oncology

Volumn 37, Issue 2, 2007, Pages 135-139

  Isobe, Koichi ^a   Kagami, Yoshikazu ^b   Higuchi, Keiko ^c   Kodaira, Takeshi ^d   Hasegawa, Masatoshi ^e   Shikama, Naoto ^f   Nakazawa, Masanori ^g   Fukuda, Ichiro ^h   Nihei, Keiji ⁱ   Ito, Kana ^j   Teshima, Teruki ^k   Oguchi, Masahiko ^l  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c GUNMA PREFECTURAL CANCER CENTER   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^j JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l CANCER INSTITUTE HOSPITAL   (Japan)

more..

Author keywords

MALT lymphoma; QA program; Quality assurance; Radiation therapy

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPACT DISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL IMAGING; DOCUMENTATION; HEALTH CARE QUALITY; HUMAN; IMAGE ANALYSIS; MEDICAL RECORD REVIEW; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORGANIZATION; POSTAL MAIL; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY CONTROL; RADIATION DOSE DISTRIBUTION; RADIODIAGNOSIS; X RAY FILM;

CLINICAL PROTOCOLS; HUMANS; JAPAN; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE;

EID: 34447630319     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl129     Document Type: Article

References (22)

1. Teshima T, Japanese PCS Working Group. Patterns of care study in Japan. Jpn J Clin Oncol 2005;35:497-506.
2. Wallner PE, Lustig RA, Pajak TF, Robinson G, Davis LW, Perez CA, et al. Impact of initial quality control review on study outcome in lung and head/neck cancer studies: Review of the Radiation Therapy Oncology Group experience. Int J Radiat Oncol Biol Phys 1989;17:893-900.
3. Bolla M, Bartelink H, Garavaglia G, Gonzalez D, Horiot JC, Johansson KA, et al. EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiother Oncol 1995;36:1-8.
4. Martin LA, Krall JM, Curran WJ, Leibel SA, Cox JD. Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials: Results of the Radiation Therapy Oncology Group (RTOG) analysis. Radiother Oncol 1995;36:9-14.
5. Thwaites D, Scalliet P, Leer JW, Overgaard J. Quality assurance in radiotherapy. Radiother Oncol 1995;35:61-73.
6. Hamilton C, Poulsen M, Walker Q, Kraqitz H, Hindley A, Spry N, et al. Quality assurance audit in an Australasian phase III trail of accelerated radiotherapy for head and neck cancer (TROG 91.01). Australas Radiol 1999;43:227-32.
7. Bentzen SM, Bernier J, Davis JB, Horiot JC, Garabaglia G, Chavaudra J, et al. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. Radiother Oncol 2000;36:615-20.
8. Ottevanger PB, Therasse P, vande Velde C, Bernier J, van Krieken H, Grol R, et al. Quality assurance in clinical trials. Crit Rev Oncol Hematol 2003;47:213-5.
9. Kouloulias VE. Quality assurance in radiotherapy. Eur J Cancer 2003;39:415-22.
10. Kouloulias VE, Poortmans PM, Bernier J, Horiot JC, Johansson KA, Davis B, et al. The quality assurance programme of the radiotherapy group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts. Eur J Cancer 2003;39:430-7.
11. Roos DE, Davis SR, Turner SL, O'Brien PC, Spry NA, Burmeister BH, et al. Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiother Oncol 2003;67:207-12.
12. Poortmans PM, Davis JB, Ataman F, Bernier J, Horiot JC, and for the EORTC Radiotherapy Group. The quality assurance programme of the radiotherapy group of the European Organisation for Research and Treatment of Cancer: Past, present and future. Eur J Surg Oncol 2005;31:667-74.
13. Ishikura S, Furutani T, Iinuma M, Teshima T, Hayakawa K, Hiraoka M, et al. The status of quality control and quality assurance of radiation therapy in clinical trials. Proc JASTRO 2005;17:S77 (in Japanese).
14. Steigler A, Mameghan H, Lamb D, Joseph D, Matthews J, Franklin I, et al. A quality assurance audit: Phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01). Australas Radiol 2000;44:65-71.
15. Halperin EC, Laurie F, Fitzgerald TJ. An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: A quality assurance review center Pediatric Oncology Group Study. Int J Radiat Oncol Biol Phys 2002;53:1001-4.
16. Duhmke E, Diehl V, Loeffler M, Mueller RP, Ruehl U, Willich N, et al. Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys 1996;36:305-10.
17. Eich KT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, et al. Centralized radiation oncology review of cross sectional imaging of Hodgkin's disease leads to significant changes in required involved field - results of a quality assurance program of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 2004;58:1121-7.
18. Eich KT, Staar S, Gossmann A, Engert A, Franklin J, Sieber M, et al. The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG). Am J Clin Oncol 2004;27:279-84.
19. Dieckmann K, Potter R, Wagner W, Prott FJ, Hornig-Franz I, Rath B, et al. Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: The experience of German-Austrian pediatric multicenter trial DAL-HD-90. Radiother Oncol 2002;62:191-200.
20. Aleman BM, Girinsky T, van der Maazen RW, Strijk S, Meijnders P, Bortolus R, et al.; European Organization for Research; Treatment of Cancer (EORTC) Lymphoma Group. Quality control of involved field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884). Int J Radiat Oncol Biol Phys 2005;63:1184-90.
21. Miralbell R, Fitzgerald TJ, Laurie F, Kessel S, Glicksman A, Friedman HS, et al. Radiotherapy in pediatric medulloblastoma: Quality assessment of Pediatric Oncology Group trial 9031. Int J Radiat Oncol Biol Phys 2006;64:1325-30.
22. Palta JR, Frouhar VA, Dempsey JF. Web-based submission, archive, and review of radiotherapy data for clinical quality assurance: A new paradigm. Int J Radiat Oncol Biol Phys 2003;57:1427-36.